URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Wallace Iglewski

TitleProfessor Emeritus
InstitutionSchool of Medicine and Dentistry
DepartmentMicrobiology and Immunology
Address3688 Nibawauka Beach
Canandaigua NY 14424
 
 Selected Publications
List All   |   Timeline
  1. Iglewski WJ. Cellular ADP-ribosylation of elongation factor 2. Mol Cell Biochem. 1994 Sep; 138(1-2):131-3.
    View in: PubMed
  2. Passador L, Iglewski W. ADP-ribosylating toxins. Methods Enzymol. 1994; 235:617-31.
    View in: PubMed
  3. Fendrick JL, Iglewski WJ, Moehring JM, Moehring TJ. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells. Eur J Biochem. 1992 Apr 1; 205(1):25-31.
    View in: PubMed
  4. Iglewski WJ, Dewhurst S. Cellular mono(ADP-ribosyl) transferase inhibits protein synthesis. FEBS Lett. 1991 Jun 3; 283(2):235-8.
    View in: PubMed
  5. Fendrick JL, Iglewski WJ. Endogenous ADP-ribosylation of elongation factor 2 in polyoma virus-transformed baby hamster kidney cells. Proc Natl Acad Sci U S A. 1989 Jan; 86(2):554-7.
    View in: PubMed
  6. Iglewski WJ, Lee H, Muller P. ADP-ribosyltransferase from beef liver which ADP-ribosylates elongation factor-2. FEBS Lett. 1984 Jul 23; 173(1):113-8.
    View in: PubMed
  7. Lee H, Iglewski WJ. Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A. Proc Natl Acad Sci U S A. 1984 May; 81(9):2703-7.
    View in: PubMed
  8. Iglewski WJ, Lee H. Purification and properties of an altered form of elongation factor 2 from mutant cells resistant to intoxication by diphtheria toxin. Eur J Biochem. 1983 Aug 1; 134(2):237-40.
    View in: PubMed
  9. Sokol PA, Iglewski BH, Hager TA, Sadoff JC, Cross AS, McManus A, Farber BF, Iglewski WJ. Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa. Infect Immun. 1981 Oct; 34(1):147-53.
    View in: PubMed
  10. Iglewski WJ, Taylor A, Hodges R, Tolle J. Intoxication of cells from different-aged embryos by diphtheria toxin. Infect Immun. 1979 Nov; 26(2):458-61.
    View in: PubMed
  11. Taylor A, Iglewski WJ. Intoxication of normal and virus-transformed cells by diphtheria toxin. Virology. 1979 Jul 15; 96(1):177-85.
    View in: PubMed
  12. Iglewski WJ, Gerhardt NB. Identification of an antibiotic-producing bacterium from the human intestinal tract and characterization of its antimicrobial product. Antimicrob Agents Chemother. 1978 Jan; 13(1):81-9.
    View in: PubMed
  13. Iglewski WJ. Changes in the capsid structure and stability of defective particles of bacteriophage R17. J Virol. 1977 Nov; 24(2):590-601.
    View in: PubMed
  14. Iglewski WJ. Production of an antibiotic by an organism from human feces. Antimicrob Agents Chemother. 1977 Jun; 11(6):1084-6.
    View in: PubMed
  15. Gerhardt NB, Iglewski WJ. Alterations in the fecal flora of an individual frequently lacking coliforms. J Infect Dis. 1976 Nov; 134(5):490-4.
    View in: PubMed
  16. Iglewski WJ. Transfection: enhancement by assembly protein of bacteriophage R17. Biochem Biophys Res Commun. 1976 Jan 12; 68(1):299-306.
    View in: PubMed
  17. Scott JW, Iglewski WJ. R17 bacteriophage replicase: association with the inhibition of Qbeta, fd bacteriophage and beta-galactosidase production. J Virol. 1975 Oct; 16(4):1077-80.
    View in: PubMed
  18. Iglewski BH, Rittenberg MB, Iglewski WJ. Preferential inhibition of growth and protein synthesis in Rous sarcoma virus transformed cells by diphtheria toxin. Virology. 1975 May; 65(1):272-5.
    View in: PubMed
  19. Scott JW, Iglewski WJ. Elimination of the early inhibition of protein synthesis in Escherichia coli C3000 infected with purified R17 bacteriophage. J Virol. 1974 Sep; 14(3):547-51.
    View in: PubMed
  20. Spangler VL, Iglewski WJ. Effect of R17 Bacteriophage-Specific Proteins on Ribosomal Ribonucleic Acid Synthesis of Escherichia coli. J Virol. 1972 May; 9(5):792-9.
    View in: PubMed
  21. Iglewski WJ. Alterations in the distribution of labeled ribonucleic acid in polyribosomes from Escherichia coli infected with bacteriophage R17. J Virol. 1971 Oct; 8(4):446-54.
    View in: PubMed
  22. Phillips LA, Truden JL, Iglewski WJ, Hotham-Iglewski B, Franklin RM. Replication of bacteriophage ribonucleic acid: alterations in polyribosome patterns in Escherichia coli infected with amber mutants of bacteriophage R17. Virology. 1969 Dec; 39(4):781-90.
    View in: PubMed
  23. Iglewski WJ, Franklin RM, Schwartz JH. The lack of messenger activity of ribonucleic acid complementary to the viral ribonucleic acid of bacteriophage R17. J Biol Chem. 1969 Feb 25; 244(4):736-43.
    View in: PubMed
  24. Iglewski WJ, Franklin RM. Denaturation and renaturation of viral RNA. 3. Purification of the complementary strand of R17 RNA. Proc Natl Acad Sci U S A. 1967 Sep; 58(3):1019-24.
    View in: PubMed
  25. Iglewski WJ, Franklin RM. Denaturation and renaturation of viral ribonucleic acd. II. Characterization of the products resulting from annealing R17 ribonucleic acid with denatured replicative form or with denatured replicative intermediate. J Virol. 1967 Aug; 1(4):804-9.
    View in: PubMed
  26. Iglewski WJ, Franklin RM. Denaturation and renaturation of viral ribonucleic acid. I. Annealing R17 ribonucleic acid with denatured replicative form or with denatured replicative intermediate. J Virol. 1967 Aug; 1(4):793-803.
    View in: PubMed
  27. Iglewski WJ, Franklin RM. Purification and properties of reovirus ribonucleic acid. J Virol. 1967 Apr; 1(2):302-7.
    View in: PubMed
  28. Iglewski WJ, Ludwig EH. Respiration of mengovirus-infected L-929 cells. J Bacteriol. 1966 Sep; 92(3):733-8.
    View in: PubMed

Visualizations


Iglewski's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department